The Packard Center and ALS United will fund a preclinical study investigating how abnormal TDP-43 protein contributes to ALS.

Pfizer has axed 11 programs, including two pipeline assets from its $43 billion Seagen acquisition, work on a ...

The official opening will be headlined by Dr Nomalungelo Gina, Deputy Minister of Science, Technology and Innovation, who ...

Moderna MRNA is set to report third-quarter 2025 earnings on Nov. 6, before the opening bell. The Zacks Consensus Estimate ...

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

Backed by fresh European financing, BioNTech’s Kigali facility is emerging as the cornerstone of Africa’s mRNA vaccine ...

In a breakthrough for diagnostics, scientists have created an easy and effective test that identifies a heart failure biomarker in saliva, opening the door to more rapid and accessible life-saving ...

By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers ...

The start of the trial marks an expansion of the firm's oncology pipeline, and the firm hopes mRNA-2808 will be the first of many T-cell engagers in its portfolio.

Yale researchers have developed a new vaccine that does double duty against a rare and aggressive skin cancer by targeting ...

MAGA and MAHA are happily married in Florida, and nowhere more at home than in Sarasota County, where on a humid October night a crowd of several hundred gathered to ...

Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has been dosed in a Phase 1/2 study of mRNA-2808, the ...